Skip to main content
. 2023 May 23;11(10):354. doi: 10.21037/atm-22-4218

Figure 1.

Figure 1

Development of the different ICIs along the last 10 years to nowadays in NSCLC. 2L, second-line; sq, squamous; NSCLC, non-small cell lung cancer; 1L, first-line; CT, chemotherapy; RT, radiotherapy; ICIs, immune checkpoint inhibitors.